Literature DB >> 20554970

Bone loss caused by iron overload in a murine model: importance of oxidative stress.

Jaime Tsay1, Zheiwei Yang, F Patrick Ross, Susanna Cunningham-Rundles, Hong Lin, Rhima Coleman, Philipp Mayer-Kuckuk, Stephen B Doty, Robert W Grady, Patricia J Giardina, Adele L Boskey, Maria G Vogiatzi.   

Abstract

Osteoporosis is a frequent problem in disorders characterized by iron overload, such as the thalassemias and hereditary hemochromatosis. The exact role of iron in the development of osteoporosis in these disorders is not established. To define the effect of iron excess in bone, we generated an iron-overloaded mouse by injecting iron dextran at 2 doses into C57/BL6 mice for 2 months. Compared with the placebo group, iron-overloaded mice exhibited dose-dependent increased tissue iron content, changes in bone composition, and trabecular and cortical thinning of bone accompanied by increased bone resorption. Iron-overloaded mice had increased reactive oxygen species and elevated serum tumor necrosis factor-α and interleukin-6 concentrations that correlated with severity of iron overload. Treatment of iron-overloaded mice with the antioxidant N-acetyl-L-cysteine prevented the development of trabecular but not cortical bone abnormalities. This is the first study to demonstrate that iron overload in mice results in increased bone resorption and oxidative stress, leading to changes in bone microarchitecture and material properties and thus bone loss.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20554970      PMCID: PMC2953890          DOI: 10.1182/blood-2009-12-260083

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  49 in total

1.  Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study.

Authors:  Dario Maggio; Mauro Barabani; Marco Pierandrei; M Cristina Polidori; Marco Catani; Patrizia Mecocci; Umberto Senin; Roberto Pacifici; Antonio Cherubini
Journal:  J Clin Endocrinol Metab       Date:  2003-04       Impact factor: 5.958

Review 2.  The dynamic interplay between osteoclasts and the immune system.

Authors:  Tomoki Nakashima; Hiroshi Takayanagi
Journal:  Arch Biochem Biophys       Date:  2008-04-08       Impact factor: 4.013

3.  Prevalence of fractures among the Thalassemia syndromes in North America.

Authors:  M G Vogiatzi; E A Macklin; E B Fung; E Vichinsky; N Olivieri; J Kwiatkowski; A Cohen; E Neufeld; P J Giardina
Journal:  Bone       Date:  2005-11-17       Impact factor: 4.398

Review 4.  Monitoring chelation therapy to achieve optimal outcome in the treatment of thalassaemia.

Authors:  John B Porter; Bernard A Davis
Journal:  Best Pract Res Clin Haematol       Date:  2002-06       Impact factor: 3.020

Review 5.  Musculoskeletal manifestations of scurvy.

Authors:  Olivier Fain
Journal:  Joint Bone Spine       Date:  2005-03       Impact factor: 4.929

Review 6.  Bone resorption by osteoclasts.

Authors:  S L Teitelbaum
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

7.  Bone mineral metabolism in adults with beta-thalassaemia major and intermedia.

Authors:  R Dresner Pollack; E Rachmilewitz; A Blumenfeld; M Idelson; A W Goldfarb
Journal:  Br J Haematol       Date:  2000-12       Impact factor: 6.998

8.  Serum ferritin in patients with iron overload and with acute and chronic liver diseases.

Authors:  J Prieto; M Barry; S Sherlock
Journal:  Gastroenterology       Date:  1975-03       Impact factor: 22.682

9.  Bone histomorphometry in children and adolescents with beta-thalassemia disease: iron-associated focal osteomalacia.

Authors:  Pat Mahachoklertwattana; Vorachai Sirikulchayanonta; Ampaiwan Chuansumrit; Patcharee Karnsombat; Lulin Choubtum; Arporn Sriphrapradang; Somnuek Domrongkitchaiporn; Rojana Sirisriro; Rajata Rajatanavin
Journal:  J Clin Endocrinol Metab       Date:  2003-08       Impact factor: 5.958

10.  Association between serum ferritin and measures of inflammation, nutrition and iron in haemodialysis patients.

Authors:  Kamyar Kalantar-Zadeh; Rudolph A Rodriguez; Michael H Humphreys
Journal:  Nephrol Dial Transplant       Date:  2004-01       Impact factor: 5.992

View more
  89 in total

1.  Bone status in a mouse model of genetic hemochromatosis.

Authors:  P Guggenbuhl; P Fergelot; M Doyard; H Libouban; M-P Roth; Y Gallois; G Chalès; O Loréal; D Chappard
Journal:  Osteoporos Int       Date:  2010-10-26       Impact factor: 4.507

2.  Steap4 plays a critical role in osteoclastogenesis in vitro by regulating cellular iron/reactive oxygen species (ROS) levels and cAMP response element-binding protein (CREB) activation.

Authors:  Jian Zhou; Shiqiao Ye; Toshifumi Fujiwara; Stavros C Manolagas; Haibo Zhao
Journal:  J Biol Chem       Date:  2013-08-29       Impact factor: 5.157

3.  Reducing iron accumulation: A potential approach for the prevention and treatment of postmenopausal osteoporosis.

Authors:  Bin Chen; Guang-Fei Li; Ying Shen; X I Huang; You-Jia Xu
Journal:  Exp Ther Med       Date:  2015-05-08       Impact factor: 2.447

4.  The unexpected presence of iron in bone biopsies of hemodialysis patients.

Authors:  Melani R Custodio; Rosilene M Elias; Wagner D Velasquez; Luciene M Dos Reis; Ivone B Oliveira; Rosa M A Moysés; Aluizio B Carvalho; Vanda Jorgetti
Journal:  Int Urol Nephrol       Date:  2018-08-22       Impact factor: 2.370

5.  Hepatic magnetic resonance imaging with T2* mapping of ovariectomized rats: correlation between iron overload and postmenopausal osteoporosis.

Authors:  Lingshan Chen; Zhengqiu Zhu; Xingui Peng; Yuancheng Wang; Yaling Wang; Min Chen; Qi Wang; Jiyang Jin
Journal:  Eur Radiol       Date:  2014-04-28       Impact factor: 5.315

6.  Iron excess upregulates SPNS2 mRNA levels but reduces sphingosine-1-phosphate export in human osteoblastic MG-63 cells.

Authors:  L Peltier; C Bendavid; T Cavey; M-L Island; M Doyard; P Leroyer; C Allain; M De Tayrac; M Ropert; O Loréal; P Guggenbuhl
Journal:  Osteoporos Int       Date:  2018-05-03       Impact factor: 4.507

7.  Deletion of ferroportin in murine myeloid cells increases iron accumulation and stimulates osteoclastogenesis in vitro and in vivo.

Authors:  Lei Wang; Bin Fang; Toshifumi Fujiwara; Kimberly Krager; Akshita Gorantla; Chaoyuan Li; Jian Q Feng; Michael L Jennings; Jian Zhou; Nukhet Aykin-Burns; Haibo Zhao
Journal:  J Biol Chem       Date:  2018-05-03       Impact factor: 5.157

8.  Dancing with sex hormones, could iron contribute to the gender difference in osteoporosis?

Authors:  Xi Huang; Youjia Xu; Nicola C Partridge
Journal:  Bone       Date:  2013-03-22       Impact factor: 4.398

9.  Iron excretion in iron dextran-overloaded mice.

Authors:  Marco Musumeci; Sonia Maccari; Alessia Massimi; Tonino Stati; Paola Sestili; Elisa Corritore; Augusto Pastorelli; Paolo Stacchini; Giuseppe Marano; Liviana Catalano
Journal:  Blood Transfus       Date:  2014-06-05       Impact factor: 3.443

10.  In vitro catabolic effect of protoporphyrin IX in human osteoblast-like cells: possible role of the 18 kDa mitochondrial translocator protein.

Authors:  Nahum Rosenberg; Orit Rosenberg; Abraham Weizman; Leo Veenman; Moshe Gavish
Journal:  J Bioenerg Biomembr       Date:  2013-03-09       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.